Pheast Therapeutics Funding: $76M Raised, Series A (2022)
Pheast Therapeutics is based in Palo Alto, California. It has raised $76M in total funding. Latest round: Series A.
Pheast Therapeutics funding overview
Pheast Therapeutics is based in Palo Alto, California. Pheast Therapeutics has raised $76M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2022. The round record for Pheast Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Catalio Capital Management, ARCH Venture Partners, Alexandria Venture Investments, Risk and Reward (R2). 4 distinct backers are named across the disclosed rounds.
Pheast Therapeutics at a glance
Total raised
$76M
Latest round
Series A
Latest round date
April 2022
Headquarters
Palo Alto, California
Notable investors
Catalio Capital Management, ARCH Venture Partners, Alexandria Venture Investments, Risk and Reward (R2)
Frequently asked about Pheast Therapeutics funding
How much has Pheast Therapeutics raised?
Pheast Therapeutics has raised $76M in total disclosed funding across the rounds on record.
Who has invested in Pheast Therapeutics?
Catalio Capital Management, ARCH Venture Partners, Alexandria Venture Investments, Risk and Reward (R2) are named among the investors backing Pheast Therapeutics.
What was the latest Pheast Therapeutics funding round?
The most recent disclosed round is a Series A, announced in April 2022.
Where is Pheast Therapeutics based?
Pheast Therapeutics is based in Palo Alto, California.
When did Pheast Therapeutics last raise?
The last disclosed Pheast Therapeutics round closed in April 2022 at Series A.
Every Pheast Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Palo Alto at a similar stage.
